These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11016633)

  • 1. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.
    Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M
    Carcinogenesis; 2003 Sep; 24(9):1561-5. PubMed ID: 12819187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of liver tumorigenesis in Connexin32-deficient mouse.
    Luebeck EG; Buchmann A; Schneider D; Moolgavkar SH; Schwarz M
    Mutat Res; 2005 Feb; 570(1):33-47. PubMed ID: 15680401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
    Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
    Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocarcinogenesis in female mice with mosaic expression of connexin32.
    Moennikes O; Buchmann A; Willecke K; Traub O; Schwarz M
    Hepatology; 2000 Sep; 32(3):501-6. PubMed ID: 10960441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains.
    Moennikes O; Buchmann A; Ott T; Willecke1 K; Schwarz M
    Carcinogenesis; 1999 Jul; 20(7):1379-82. PubMed ID: 10383916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promotion in liver of mice with a conditional Cx26 knockout.
    Marx-Stoelting P; Mahr J; Knorpp T; Schreiber S; Templin MF; Ott T; Buchmann A; Schwarz M
    Toxicol Sci; 2008 Jun; 103(2):260-7. PubMed ID: 18308698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
    Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
    Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat.
    Hokaiwado N; Asamoto M; Ogawa K; Shirai T
    Toxicol Pathol; 2005; 33(6):695-701. PubMed ID: 16243774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
    Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver.
    Neveu MJ; Hully JR; Babcock KL; Hertzberg EL; Nicholson BJ; Paul DL; Pitot HC
    J Cell Sci; 1994 Jan; 107 ( Pt 1)():83-95. PubMed ID: 8175925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the tumor promoter phenobarbital on the pattern of global gene expression in liver of connexin32-wild-type and connexin32-deficient mice.
    Stahl S; Ittrich C; Marx-Stoelting P; Köhle C; Ott T; Buchmann A; Schwarz M
    Int J Cancer; 2005 Jul; 115(6):861-9. PubMed ID: 15751032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a high-sucrose diet on the development of enzyme-altered foci in chemical hepatocarcinogenesis in rats.
    Hei TK; Sudilovsky O
    Cancer Res; 1985 Jun; 45(6):2700-5. PubMed ID: 2859110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactive effects of unleaded gasoline and estrogen on liver tumor promotion in female B6C3F1 mice.
    Standeven AM; Wolf DC; Goldsworthy TL
    Cancer Res; 1994 Mar; 54(5):1198-204. PubMed ID: 8118806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis.
    Phillips JM; Yamamoto Y; Negishi M; Maronpot RR; Goodman JI
    Toxicol Sci; 2007 Mar; 96(1):72-82. PubMed ID: 17172636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.
    Neveu MJ; Hully JR; Paul DL; Pitot HC
    Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
    Rignall B; Braeuning A; Buchmann A; Schwarz M
    Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice.
    Evert M; Ott T; Temme A; Willecke K; Dombrowski F
    Carcinogenesis; 2002 May; 23(5):697-703. PubMed ID: 12016140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32.
    Temme A; Buchmann A; Gabriel HD; Nelles E; Schwarz M; Willecke K
    Curr Biol; 1997 Sep; 7(9):713-6. PubMed ID: 9285723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.